Ethan O Perlstein

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Anti Inflammatory Drugs

Drosophila Melanogaster

Induced Pluripotent Stem Cells

Top Venues

G3 (Bethesda, Md.)

Disease models & mechanisms

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan C Vignogna, Mariateresa Allocca, Maria Monticelli, Joy W Norris, Richard A Steet, Ethan O Perlstein, Giuseppina Andreotti, Gregory I Lang
Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease. eLife 11 (2022)
Jessica P Lao, Nina DiPrimio, Madeleine Prangley, Feba S Sam, Joshua D Mast, Ethan O Perlstein
Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation. G3 (Bethesda, Md.) 9 (2) (2019)
Sangeetha Iyer, Joshua D Mast, Hillary Tsang, Tamy P Rodriguez, Nina DiPrimio, Madeleine Prangley, Feba S Sam, Zachary Parton, Ethan O Perlstein
Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches. Disease models & mechanisms 12 (11) (2019)
Sangeetha Iyer, Feba S Sam, Nina DiPrimio, Graeme Preston, Jan Verheijen, Kausalya Murthy, Zachary Parton, Hillary Tsang, Jessica P Lao, Eva Morava, Ethan O Perlstein
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Disease models & mechanisms 12 (11) (2019)
Tamy Portillo Rodriguez, Joshua D Mast, Tom Hartl, Tom Lee, Peter Sand, Ethan O Perlstein
Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a Drosophila Model of NGLY1 Deficiency. G3 (Bethesda, Md.) 8 (7) (2018)